The decision to continue, adjust, or discontinue therapy should be based on objective body composition measurements (DEXA scans, circumference measurements), achievement of fat loss goals, tolerance and side effect profile, and physician assessment of metabolic markers
Mohs RC, Davis KL, Tinklenberg JR, Hollister LE
Clinical trial results Sarcoidosis-associated small fiber neuropathy: In a blinded, placebo-controlled trial, 28 days of daily subcutaneous ARA-290 administration in patients with documented small nerve fiber loss produced significant improvements
I am starting with BPC157
So und zustzlich ber verschiedene andere Mechanismen untersttzt Glutathion nachhaltig die Immunabwehr und vermindert das Risiko fr Folgeerkrankungen nach Infektionen